Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/20667
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiendl, H.-
dc.contributor.authorGross, C. C.-
dc.contributor.authorLindner, M.-
dc.contributor.authorEschborn, M.-
dc.contributor.authorWeisser, L.-
dc.contributor.authorPosevitz-Fejfar, A.-
dc.contributor.authorSchulte-Mecklenbeck, A.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorHupperts, R.-
dc.contributor.authorLunven, C.-
dc.contributor.authorBrette, S.-
dc.contributor.authorTurner, T. J.-
dc.contributor.authorKlotz, L.-
dc.date.accessioned2016-02-17T08:47:42Z-
dc.date.available2016-02-17T08:47:42Z-
dc.date.issued2015-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 21 (S11), p. 532-533-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/20667-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleCharacterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMIC-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 07-10, 2015-
local.bibliographicCitation.conferencename31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-
local.bibliographicCitation.conferenceplaceBarcelona, SPAIN-
dc.identifier.epage533-
dc.identifier.issueS11-
dc.identifier.spage532-
dc.identifier.volume21-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Wiendl, H.; Gross, C. C.; Lindner, M.; Eschborn, M.; Weisser, L.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; Klotz, L.] Univ Munster, D-48149 Munster, Germany. [Van Wijmeersch, B.] Hasselt Univ, Hasselt, Belgium. [Hupperts, R.] Maastricht Univ, NL-6200 MD Maastricht, Netherlands. [Lunven, C.] Sanofi, Chilly Mazarin, France. [Brette, S.] Lincoln, Boulogne, France. [Turner, T. J.] Genzyme, Cambridge, MA USA.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000365729401420-
item.fulltextWith Fulltext-
item.contributorWiendl, H.-
item.contributorGross, C. C.-
item.contributorLindner, M.-
item.contributorEschborn, M.-
item.contributorWeisser, L.-
item.contributorPosevitz-Fejfar, A.-
item.contributorSchulte-Mecklenbeck, A.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorHupperts, R.-
item.contributorLunven, C.-
item.contributorBrette, S.-
item.contributorTurner, T. J.-
item.contributorKlotz, L.-
item.fullcitationWiendl, H.; Gross, C. C.; Lindner, M.; Eschborn, M.; Weisser, L.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; VAN WIJMEERSCH, Bart; Hupperts, R.; Lunven, C.; Brette, S.; Turner, T. J. & Klotz, L. (2015) Characterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMIC. In: MULTIPLE SCLEROSIS JOURNAL, 21 (S11), p. 532-533.-
item.accessRightsRestricted Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Mult Scler-2015--76-653.pdf
  Restricted Access		895.6 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.